Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection

Tumor necrosis factor-alpha (TNF-α) blockade is an effective treatment for rheumatoid arthritis (RA) and other inflammatory diseases, but in patients, it is associated with reduced resistance to the infectious agents Mycobacterium tuberculosis and Listeria monocytogenes, among others. Our goal was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Belmellat, Nadia, Semerano, Luca, Segueni, Noria, Damotte, Diane, Decker, Patrice, Ryffel, Bernhard, Quesniaux, Valérie, Boissier, Marie-Christophe, Assier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694445/
https://www.ncbi.nlm.nih.gov/pubmed/29184553
http://dx.doi.org/10.3389/fimmu.2017.01533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694445/
https://www.ncbi.nlm.nih.gov/pubmed/29184553
http://dx.doi.org/10.3389/fimmu.2017.01533

Ejemplares similares